More likely he simply doesn't care. A lot of what'
Post# of 145248
DoctoRx owns GSK and is boosting GSK at the expense of GILD. I just skimmed through the article very fast but some of his assertations seemed off.
Mentioning a competitor that will take market share away from GSK diminishes his boosting of GSK.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)